| Dr Amy Lynn Lobrano, MD | |
|
9103 Jefferson Hwy, Baton Rouge, LA 70809-2440 | |
| (225) 927-1190 | |
| (225) 706-0160 |
| Full Name | Dr Amy Lynn Lobrano |
|---|---|
| Gender | Female |
| Speciality | Gastroenterology |
| Experience | 24 Years |
| Location | 9103 Jefferson Hwy, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255382909 | NPI | - | NPPES |
| 1581976 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 200745 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Health Presbyterian Hospital Plano | Plano, TX | Hospital |
| Baptist Memorial Hospital Desoto | Southaven, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Texas Digestive Disease Consultants Pllc | 3375531379 | 544 |
| Texas Digestive Disease Consultants Pllc | 3375531379 | 544 |
News Archive
'Macho, bullying, and unfriendly workplace cultures' are a common experience of ethnic minority women in the UK labour market and workplace, according to a major new study published today, (Thursday, 5 July 2007) yet good management and positive role models make a difference.
Mitchell Warren, executive director of AVAC: Global Advocacy for HIV Prevention and a founding member of the Global Health Technologies Coalition, writing in The Hill's "Congress Blog," welcomes Secretary of State Hillary Rodham Clinton's November 8 announcement of "an additional $60 million for implementation of a combination of prevention strategies in four sub-Saharan African countries and evaluation of their impact," adding that "this funding can only be viewed as a down payment on the work that needs to be done."
AEterna Zentaris Inc. has presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
The maximal standardized uptake value (called SUVmax) measured from FDG PET readings taken from the primary tumor in head and neck squamous cell carcinoma patients before treatment is a strong predictor of disease-specific survival, overall survival and disease-free survival, while pretreatment SUVmax for lymphodenopathy is strongly associated with distant metastasis, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.
› Verified 7 days ago
| Entity Name | Lsuhn Billing Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992975775 PECOS PAC ID: 0446337802 Enrollment ID: O20080409000372 |
News Archive
'Macho, bullying, and unfriendly workplace cultures' are a common experience of ethnic minority women in the UK labour market and workplace, according to a major new study published today, (Thursday, 5 July 2007) yet good management and positive role models make a difference.
Mitchell Warren, executive director of AVAC: Global Advocacy for HIV Prevention and a founding member of the Global Health Technologies Coalition, writing in The Hill's "Congress Blog," welcomes Secretary of State Hillary Rodham Clinton's November 8 announcement of "an additional $60 million for implementation of a combination of prevention strategies in four sub-Saharan African countries and evaluation of their impact," adding that "this funding can only be viewed as a down payment on the work that needs to be done."
AEterna Zentaris Inc. has presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
The maximal standardized uptake value (called SUVmax) measured from FDG PET readings taken from the primary tumor in head and neck squamous cell carcinoma patients before treatment is a strong predictor of disease-specific survival, overall survival and disease-free survival, while pretreatment SUVmax for lymphodenopathy is strongly associated with distant metastasis, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.
› Verified 7 days ago
| Entity Name | Texas Digestive Disease Consultants Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154837391 PECOS PAC ID: 3375531379 Enrollment ID: O20180125001639 |
News Archive
'Macho, bullying, and unfriendly workplace cultures' are a common experience of ethnic minority women in the UK labour market and workplace, according to a major new study published today, (Thursday, 5 July 2007) yet good management and positive role models make a difference.
Mitchell Warren, executive director of AVAC: Global Advocacy for HIV Prevention and a founding member of the Global Health Technologies Coalition, writing in The Hill's "Congress Blog," welcomes Secretary of State Hillary Rodham Clinton's November 8 announcement of "an additional $60 million for implementation of a combination of prevention strategies in four sub-Saharan African countries and evaluation of their impact," adding that "this funding can only be viewed as a down payment on the work that needs to be done."
AEterna Zentaris Inc. has presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
The maximal standardized uptake value (called SUVmax) measured from FDG PET readings taken from the primary tumor in head and neck squamous cell carcinoma patients before treatment is a strong predictor of disease-specific survival, overall survival and disease-free survival, while pretreatment SUVmax for lymphodenopathy is strongly associated with distant metastasis, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amy Lynn Lobrano, MD 9103 Jefferson Hwy, Baton Rouge, LA 70809-2440 Ph: (225) 927-1190 | Dr Amy Lynn Lobrano, MD 9103 Jefferson Hwy, Baton Rouge, LA 70809-2440 Ph: (225) 927-1190 |
News Archive
'Macho, bullying, and unfriendly workplace cultures' are a common experience of ethnic minority women in the UK labour market and workplace, according to a major new study published today, (Thursday, 5 July 2007) yet good management and positive role models make a difference.
Mitchell Warren, executive director of AVAC: Global Advocacy for HIV Prevention and a founding member of the Global Health Technologies Coalition, writing in The Hill's "Congress Blog," welcomes Secretary of State Hillary Rodham Clinton's November 8 announcement of "an additional $60 million for implementation of a combination of prevention strategies in four sub-Saharan African countries and evaluation of their impact," adding that "this funding can only be viewed as a down payment on the work that needs to be done."
AEterna Zentaris Inc. has presented a poster outlining Phase 1 results for its orally-active tubulin and topoisomerase II inhibitor compound, AEZS-112, in patients with advanced solid tumors or lymphoma, which may potentially provide a new therapeutic approach for the treatment of cancer.
The maximal standardized uptake value (called SUVmax) measured from FDG PET readings taken from the primary tumor in head and neck squamous cell carcinoma patients before treatment is a strong predictor of disease-specific survival, overall survival and disease-free survival, while pretreatment SUVmax for lymphodenopathy is strongly associated with distant metastasis, according to a study presented at the Multidisciplinary Head and Neck Cancer Symposium, sponsored by AHNS, ASCO, ASTRO and SNM.
› Verified 7 days ago
Dr. Jennifer L Rippon, D.O. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd Ste 409, Baton Rouge, LA 70808 Phone: 225-765-5864 Fax: 225-765-2013 | |
Gregory Fusilier, M.D. Gastroenterology Medicare: Medicare Enrolled Practice Location: 9103 Jefferson Hwy, Baton Rouge, LA 70809 Phone: 225-927-1190 Fax: 225-927-0988 | |
Dr. Yolanda Maria O'rourke, Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 7968 Essen Park, Baton Rouge, LA 70809 Phone: 225-761-6700 Fax: 225-761-6760 | |
Patricia D. Whatley, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7373 Perkins Rd, Attn: Dee / Administration, Baton Rouge, LA 70808 Phone: 225-769-4044 | |
Frederick Cerise, Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 3810 W Lakeshore Dr, Baton Rouge, LA 70808 Phone: 225-578-8886 | |
Dr. Jon Richard Jackson, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5000 Hennessy Blvd, Baton Rouge, LA 70808 Phone: 225-765-4050 Fax: 225-765-4046 | |
Richard Frank Burroughs, MD Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: Earl K. Long Hospital, Lsu Unit, 5825 Airline Highway, Baton Rouge, LA 70805 Phone: 225-358-3938 |